The microbiome in lung cancer tissue and recurrence-free survival
Cancer Epidemiology, Biomarkers & Prevention Feb 14, 2019
Peters BA, et al. - In this pilot study, researchers studied the link between lung microbiota and lung cancer prognosis in 19 non-small cell lung cancer patients. They performed 16S rRNA gene sequencing on paired lung tumor and remote normal samples from the same lobe/segment. They assessed recurrence-free and disease-free survival in correlation with tumor or normal tissue microbiome diversity and composition. Findings revealed an association between higher richness and diversity in normal tissue and reduced recurrence-free survival and disease-free survival, as was normal tissue overall microbiome composition. Increased recurrence-free and disease-free survival were observed in relation to greater abundance of family Koribacteraceae in normal tissue, while reduced recurrence-free or disease-free survival were evident in relation to greater abundance of families Bacteroidaceae, Lachnospiraceae, and Ruminococcaceae. Findings, for the first time, highlighted a potential link between the normal lung microbiota and lung cancer prognosis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries